Curidium Medica plc ("Curidium" or the "Company")
Curidium Announces Director's Purchase of Company Shares
LONDON, UK, 20 May 2008, Curidium Medica plc, (LSE : CUR ), a personalized
medicine company focused on bringing the right drug to the right
patient, announced today that director Rob Smith, Finance Director,
today has purchased 1,825 ordinary shares in the Company at a price of
54.8 pence per share.
Following this transaction, Rob Smith is interested
in 8,491 shares representing approximately 0.046 per cent of the
Company's total issued share capital.
- END -
For further information, please contact:
Rob Smith +44 (0)20 7383 5345
Finance Director, Curidium Medica plc
Charlie Cunningham +44 (0)20 7600 1658
JM Finn Capital Markets Ltd
Billy Clegg / Edward Westropp / Annie Evangeli + 44 (0)20 7831 3113
Financial Dynamics
This information is provided by RNS
The company news service from the London Stock Exchange
END
Contact Information: Contacts: RNS Customer Services 0044-207797-4400 http://www.rns.com